Provepharm life Solutions Funding: $142M Raised, Series B
Provepharm life Solutions is based in Marseille, France. It has raised $142M in total funding. Latest round: Series B.
Provepharm life Solutions funding overview
Provepharm life Solutions is based in Marseille, France. Provepharm life Solutions has raised $142M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for Provepharm life Solutions runs through 2021; nothing later has been disclosed. Investors on record include Tikehau Capital, Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence, Bpifrance. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Provepharm life Solutions funding
How much has Provepharm life Solutions raised?
Provepharm life Solutions has raised $142M in total disclosed funding across the rounds on record.
Who has invested in Provepharm life Solutions?
Tikehau Capital, Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence, Bpifrance are named among the investors backing Provepharm life Solutions.
What was the latest Provepharm life Solutions funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is Provepharm life Solutions based?
Provepharm life Solutions is based in Marseille, France.
When did Provepharm life Solutions last raise?
The last disclosed Provepharm life Solutions round closed in September 2021 at Series B.
Round data for Provepharm life Solutions is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Marseille and backer lists below.
Companies related to Provepharm life Solutions (18)
